{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:12:49Z","timestamp":1762161169617},"reference-count":28,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.3892\/or.2015.4120","type":"journal-article","created":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T05:23:59Z","timestamp":1436419439000},"page":"1494-1502","source":"Crossref","is-referenced-by-count":28,"title":["STC2 overexpression mediated by HMGA2 is a biomarker for aggressiveness of high-grade serous ovarian cancer"],"prefix":"10.3892","volume":"34","author":[{"given":"JINGJING","family":"WU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAODE","family":"LAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHANGSHUN","family":"SHAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIAN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIAN-JUN","family":"WEI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,7,9]]},"reference":[{"key":"key20180107211822_b1-or-34-03-1494","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"key20180107211822_b2-or-34-03-1494","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrclinonc.2013.5","article-title":"Latest research and treatment of advanced-stage epithelial ovarian cancer","volume":"10","author":"Coleman","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"key20180107211822_b3-or-34-03-1494","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"key20180107211822_b4-or-34-03-1494","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.4161\/cc.6.21.4845","article-title":"Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2","volume":"6","author":"Park","year":"2007","journal-title":"Cell Cycle"},{"key":"key20180107211822_b5-or-34-03-1494","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1073\/pnas.98.3.1176","article-title":"Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer","volume":"98","author":"Welsh","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107211822_b6-or-34-03-1494","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/PAS.0b013e3181be5d72","article-title":"HMGA2: A potential biomarker complement to P53 for detection of early-stage high-grade papillary serous carcinoma in fallopian tubes","volume":"34","author":"Wei","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"key20180107211822_b7-or-34-03-1494","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1158\/0008-5472.CAN-10-2550","article-title":"HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes","volume":"71","author":"Wu","year":"2011","journal-title":"Cancer Res"},{"key":"key20180107211822_b8-or-34-03-1494","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ijc.23491","article-title":"HMGA2 gene is a promising target for ovarian cancer silencing therapy","volume":"123","author":"Malek","year":"2008","journal-title":"Int J Cancer"},{"key":"key20180107211822_b9-or-34-03-1494","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00109-013-1055-8","article-title":"HMGA2 and high-grade serous ovarian carcinoma","volume":"91","author":"Wu","year":"2013","journal-title":"J Mol Med Berl"},{"key":"key20180107211822_b10-or-34-03-1494","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1158\/0008-5472.CAN-12-3848","article-title":"HMGA2 is a driver of tumor metastasis","volume":"73","author":"Morishita","year":"2013","journal-title":"Cancer Res"},{"key":"key20180107211822_b11-or-34-03-1494","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s10620-012-2399-6","article-title":"HMGA2 elicits EMT by activating the Wnt\/\u03b2-catenin pathway in gastric cancer","volume":"58","author":"Zha","year":"2013","journal-title":"Dig Dis Sci"},{"key":"key20180107211822_b12-or-34-03-1494","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2141.2002.03916.x","article-title":"Expression of stanniocalcin-1 in megakaryocytes and platelets","volume":"119","author":"Serlachius","year":"2002","journal-title":"Br J Haematol"},{"key":"key20180107211822_b13-or-34-03-1494","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0303-7207(98)00097-5","article-title":"Identification of a second stanniocalcin cDNA in mouse and human: Stanniocalcin 2","volume":"141","author":"Chang","year":"1998","journal-title":"Mol Cell Endocrinol"},{"key":"key20180107211822_b14-or-34-03-1494","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djq127","article-title":"Stanniocalcin 1 and ovarian tumorigenesis","volume":"102","author":"Liu","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"key20180107211822_b15-or-34-03-1494","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/ijc.24453","article-title":"Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer","volume":"125","author":"Ieta","year":"2009","journal-title":"Int J Cancer"},{"key":"key20180107211822_b16-or-34-03-1494","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1158\/0008-5472.CAN-12-0656","article-title":"Multilevel whole-genome analysis reveals candidate biomarkers in clear cell renal cell carcinoma","volume":"72","author":"Girgis","year":"2012","journal-title":"Cancer Res"},{"key":"key20180107211822_b17-or-34-03-1494","doi-asserted-by":"crossref","first-page":"698","DOI":"10.4149\/neo_2013_089","article-title":"Comparative study of clinicopathological significance, BIRC7, and STC2 expression between squamous cell\/adenosquamous carcinomas and adenocarcinoma of gallbladder","volume":"60","author":"Yuan","year":"2013","journal-title":"Neoplasma"},{"key":"key20180107211822_b18-or-34-03-1494","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1200\/JCO.2006.08.8583","article-title":"Tumor vascular proteins as biomarkers in ovarian cancer","volume":"25","author":"Buckanovich","year":"2007","journal-title":"J Clin Oncol"},{"key":"key20180107211822_b19-or-34-03-1494","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.yexcr.2009.09.018","article-title":"Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia","volume":"316","author":"Law","year":"2010","journal-title":"Exp Cell Res"},{"key":"key20180107211822_b20-or-34-03-1494","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/modpathol.2012.118","article-title":"Expression analysis of MIR182 and its associated target genes in advanced ovarian carcinoma","volume":"25","author":"McMillen","year":"2012","journal-title":"Mod Pathol"},{"key":"key20180107211822_b21-or-34-03-1494","doi-asserted-by":"crossref","first-page":"13059","DOI":"10.1021\/bi701269s","article-title":"Specific recognition of AT-rich DNA sequences by the mammalian high mobility group protein AT-hook 2: A SELEX study","volume":"46","author":"Cui","year":"2007","journal-title":"Biochemistry"},{"key":"key20180107211822_b22-or-34-03-1494","first-page":"1289","article-title":"Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer","volume":"62","author":"Bouras","year":"2002","journal-title":"Cancer Res"},{"key":"key20180107211822_b23-or-34-03-1494","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1016\/j.yexcr.2010.06.026","article-title":"Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells","volume":"316","author":"Law","year":"2010","journal-title":"Exp Cell Res"},{"key":"key20180107211822_b24-or-34-03-1494","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1245\/s10434-010-1086-0","article-title":"Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer","volume":"17","author":"Yokobori","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"key20180107211822_b25-or-34-03-1494","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1477-7819-11-81","article-title":"Clinical utility of measuring expression levels of KAP1, TIMP1 and STC2 in peripheral blood of patients with gastric cancer","volume":"11","author":"Wang","year":"2013","journal-title":"World J Surg Oncol"},{"key":"key20180107211822_b26-or-34-03-1494","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/ijc.24564","article-title":"Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma","volume":"125","author":"Volland","year":"2009","journal-title":"Int J Cancer"},{"key":"key20180107211822_b27-or-34-03-1494","doi-asserted-by":"crossref","first-page":"629","DOI":"10.5483\/BMBRep.2012.45.11.086","article-title":"STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro","volume":"45","author":"Wang","year":"2012","journal-title":"BMB Rep"},{"key":"key20180107211822_b28-or-34-03-1494","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1158\/0008-5472.CAN-11-1698","article-title":"Integrative genomic analyses of sporadic clear cell renal cell carcinoma define disease subtypes and potential new therapeutic targets","volume":"72","author":"Dondeti","year":"2012","journal-title":"Cancer Res"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2015.4120\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T16:18:34Z","timestamp":1515341914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2015.4120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,9]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,7,9]]},"published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.3892\/or.2015.4120"],"URL":"https:\/\/doi.org\/10.3892\/or.2015.4120","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,9]]}}}